These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30226584)

  • 1. CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.
    Liu Q; Fan D; Adah D; Wu Z; Liu R; Yan QT; Zhang Y; Du ZY; Wang D; Li Y; Bao SY; Liu LP
    Oncol Rep; 2018 Nov; 40(5):2547-2557. PubMed ID: 30226584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non‑coding RNA MIAT knockdown potentiates the therapeutic effect of transcatheter arterial embolization in liver cancer by regulating the miR‑203a/HIF‑1α axis.
    Liu J; Cao G; Liu J; Zhao X; Cao H
    Oncol Rep; 2020 Aug; 44(2):722-734. PubMed ID: 32468055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.
    Lin WH; Yeh SH; Yeh KH; Chen KW; Cheng YW; Su TH; Jao P; Ni LC; Chen PJ; Chen DS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11937-11942. PubMed ID: 27702890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.
    Ibrahim AA; Schmithals C; Kowarz E; Köberle V; Kakoschky B; Pleli T; Kollmar O; Nitsch S; Waidmann O; Finkelmeier F; Zeuzem S; Korf HW; Schmid T; Weigert A; Kronenberger B; Marschalek R; Piiper A
    Clin Cancer Res; 2017 Jul; 23(14):3896-3905. PubMed ID: 28167508
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma.
    Wang GZ; Fang ZT; Zhang W; Qu XD; Qian S; Liu R; Wang JH
    Oncol Rep; 2014 Jan; 31(1):95-102. PubMed ID: 24173823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma.
    Wei X; Zhao L; Ren R; Ji F; Xue S; Zhang J; Liu Z; Ma Z; Wang XW; Wong L; Liu N; Shi J; Guo X; Roessler S; Zheng X; Ji J
    Hepatology; 2021 Apr; 73(4):1381-1398. PubMed ID: 32609900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
    Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
    Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
    Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
    J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4.
    Jiang Z; Zhang C; Liu X; Ma X; Bian X; Xiao X; Gao R; Sun Y; Wu W; Zhao P
    Int J Oncol; 2020 Sep; 57(3):780-790. PubMed ID: 32705164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
    Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma.
    Lai RK; Xu IM; Chiu DK; Tse AP; Wei LL; Law CT; Lee D; Wong CM; Wong MP; Ng IO; Wong CC
    Clin Cancer Res; 2016 Jun; 22(12):3105-17. PubMed ID: 26819450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y; Gao F; Song W
    Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hypoxia‑inducible adrenomedullin using RNA interference attenuates hepatocellular carcinoma cell growth in vivo.
    Li F; Yang R; Zhang X; Liu A; Zhao Y; Guo Y
    Mol Med Rep; 2014 Sep; 10(3):1295-302. PubMed ID: 24927229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-375 Impairs the Invasive Capabilities of Hepatoma Cells by Targeting HIF1α Under Hypoxia.
    Wang C; Luo J; Chen Z; Ye M; Hong Y; Liu J; Nie J; Zhao Q; Chang Y
    Dig Dis Sci; 2021 Feb; 66(2):493-502. PubMed ID: 32215815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
    Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
    Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
    Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
    Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma.
    Jiao HK; Xu Y; Li J; Wang W; Mei Z; Long XD; Chen GQ
    Cell Death Dis; 2015 Mar; 6(3):e1689. PubMed ID: 25766328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.